Home NDC 69853-0202 BEVYXXA
Product NDC 69853-0202
11-digit product format 698530202
Labeler code 69853
Product ID 69853-0202_2e844c6c-8a74-441c-bb92-30c34b0dce08
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name betrixaban
Dosage form CAPSULE, GELATIN COATED
Route ORAL
Labeler Portola Pharmaceuticals, Inc.
Application NDA208383
Marketing category NDA
Marketing start 2017-07-07
Marketing end 0000-00-00
Substance BETRIXABAN
Active strength 40 mg/1
Pharmacologic classes Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 69853-0202-1 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 69853-0202-1 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 69853-0202-1 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 69853-0202-1 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 69853-0202-1 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 69853-0202-1 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 69853-0202-1 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 69853-0202-1 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 69853-0202-1 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 69853-0202-1 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 69853-0202-1 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 69853-0202-1 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208383-001 BEVYXXA BETRIXABAN 40MG CAPSULE / ORAL RLD 2017-06-23 N208383-002 BEVYXXA BETRIXABAN 80MG CAPSULE / ORAL RLD 2017-06-23
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N208383-001 9555023 2026-11-07 U-1502 2017-07-21 N208383-001 7598276 2026-11-08 Drug substance 2017-07-21 N208383-001 8557852 2028-09-08 U-1167 2017-07-21 N208383-001 8557852 2028-09-08 U-2030 2017-07-21 N208383-001 8987463 2030-12-28 Drug product 2017-07-21 N208383-001 8404724 2031-03-29 U-2034 Drug product 2017-07-21 N208383-002 9555023 2026-11-07 U-1502 2017-07-21 N208383-002 7598276 2026-11-08 Drug substance 2017-07-21 N208383-002 8557852 2028-09-08 U-1167 2017-07-21 N208383-002 8557852 2028-09-08 U-2030 2017-07-21 N208383-002 8987463 2030-12-28 Drug product 2017-07-21 N208383-002 8404724 2031-03-29 U-2034 Drug product 2017-07-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD 2017-06-23 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208383-001 BEVYXXA 40MG CAPSULE / ORAL RLD 2017-06-23 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N208383-002 BEVYXXA 80MG CAPSULE / ORAL RLD, RS 2017-06-23 74a2ff9319b5…
Observed Orange Book patent history# Patent history page 1 of 17 · 660 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N208383-001 9555023 2026-11-07 U-1502 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-001 7598276 2026-11-08 Drug substance 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-001 8557852 2028-09-08 U-1167 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-001 8557852 2028-09-08 U-2030 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-001 8987463 2030-12-28 Drug product 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-001 8404724 2031-03-29 U-2034 Drug product 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-002 9555023 2026-11-07 U-1502 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-002 7598276 2026-11-08 Drug substance 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-002 8557852 2028-09-08 U-1167 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-002 8557852 2028-09-08 U-2030 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-002 8987463 2030-12-28 Drug product 2017-07-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208383-002 8404724 2031-03-29 U-2034 Drug product 2017-07-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208383-001 9555023 2026-11-07 U-1502 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-001 7598276 2026-11-08 Drug substance 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-001 8557852 2028-09-08 U-1167 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-001 8557852 2028-09-08 U-2030 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-001 8987463 2030-12-28 Drug product 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-001 8404724 2031-03-29 U-2034 Drug product 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-002 9555023 2026-11-07 U-1502 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-002 7598276 2026-11-08 Drug substance 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-002 8557852 2028-09-08 U-1167 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-002 8557852 2028-09-08 U-2030 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-002 8987463 2030-12-28 Drug product 2017-07-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208383-002 8404724 2031-03-29 U-2034 Drug product 2017-07-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208383-001 9555023 2026-11-07 U-1502 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-001 7598276 2026-11-08 Drug substance 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-001 8557852 2028-09-08 U-1167 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-001 8557852 2028-09-08 U-2030 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-001 8987463 2030-12-28 Drug product 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-001 8404724 2031-03-29 U-2034 Drug product 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-002 9555023 2026-11-07 U-1502 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-002 7598276 2026-11-08 Drug substance 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-002 8557852 2028-09-08 U-1167 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-002 8557852 2028-09-08 U-2030 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-002 8987463 2030-12-28 Drug product 2017-07-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208383-002 8404724 2031-03-29 U-2034 Drug product 2017-07-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208383-001 9555023 2026-11-07 U-1502 2017-07-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208383-001 7598276 2026-11-08 Drug substance 2017-07-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208383-001 8557852 2028-09-08 U-1167 2017-07-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208383-001 8557852 2028-09-08 U-2030 2017-07-21 31067a03dcf5…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.